Desflurane hepatitis associated with hapten and autoantigen-specific IgG4 antibodies

被引:23
作者
Anderson, James S.
Rose, Noel R.
Martin, Jackie L.
Eger, Edmond I.
Njoku, Dolores B.
机构
[1] Johns Hopkins Med Instit, Dept Anesthesia & Crit Care Med, Baltimore, MD 21287 USA
[2] Johns Hopkins Med Instit, Dept Pathol, Baltimore, MD 21287 USA
[3] Johns Hopkins Med Instit, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21287 USA
[4] Anesthesia Consultants Associated, El Paso, TX USA
[5] Univ Calif San Francisco, San Francisco, CA 94143 USA
关键词
D O I
10.1213/01.ane.0000263275.10081.47
中图分类号
R614 [麻醉学];
学科分类号
100217 [麻醉学];
摘要
BACKGROUND: Three cases of drug-induced liver injury (DILI) have been reported after desflurane anesthesia. However, no previous reports have detected serum autoantibodies such as that reported with DILI from halothane or isoflurane. METHODS AND RESULTS: We describe the first documentation of cytochrome P450 2E1 IgG4 autoantibodies, as well as 58 kDa endoplasmic reticulum protein and trifluoroacetyl chloride hapten-specific IgG4 antibodies, in a patient who developed DILI after desflurane anesthesia. CONCLUSIONS: These findings suggest that allergic and autoimmune mechanisms have critical roles in the development of desflurane DILI.
引用
收藏
页码:1452 / 1453
页数:2
相关论文
共 16 条
[1]
Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis [J].
Bourdi, M ;
Chen, WQ ;
Peter, RM ;
Martin, JL ;
Buters, JTM ;
Nelson, SD ;
Pohl, LR .
CHEMICAL RESEARCH IN TOXICOLOGY, 1996, 9 (07) :1159-1166
[2]
Eliasson E, 1996, MOL PHARMACOL, V50, P573
[3]
KATZ J, 1994, ANESTH ANALG, V78, P1173
[4]
Recognizing drug-induced liver injury: Current problems, possible solutions [J].
Lee, WM ;
Senior, JR .
TOXICOLOGIC PATHOLOGY, 2005, 33 (01) :155-164
[5]
HEPATOTOXICITY AFTER DESFLURANE ANESTHESIA [J].
MARTIN, JL ;
PLEVAK, DJ ;
FLANNERY, KD ;
CHARLTON, M ;
POTERUCHA, JJ ;
HUMPHREYS, CE ;
DERFUS, G ;
POHL, LR .
ANESTHESIOLOGY, 1995, 83 (05) :1125-1129
[6]
ASSOCIATION OF ANTI-58 KDA ENDOPLASMIC-RETICULUM ANTIBODIES WITH HALOTHANE HEPATITIS [J].
MARTIN, JL ;
REED, GF ;
POHL, LR .
BIOCHEMICAL PHARMACOLOGY, 1993, 46 (07) :1247-1250
[7]
NEUBERGER J, 1981, GUT, V22, P669, DOI 10.1136/gut.22.8.669
[8]
Biotransformation of halothane, enflurane, isoflurane, and desflurane to trifluoroacetylated liver proteins: Association between protein acylation and hepatic injury [J].
Njoku, D ;
Laster, MJ ;
Gong, DH ;
Eger, EI ;
Reed, GF ;
Martin, JL .
ANESTHESIA AND ANALGESIA, 1997, 84 (01) :173-178
[9]
Role of CYP2E1 immunoglobulin G4 subclass antibodies and complement in pathogenesis of idiosyncratic drug-induced hepatitis [J].
Njoku, DB ;
Mellerson, JL ;
Talor, MV ;
Kerr, DR ;
Faraday, NR ;
Outschoorn, I ;
Rose, NR .
CLINICAL AND VACCINE IMMUNOLOGY, 2006, 13 (02) :258-265
[10]
A novel model of drug hapten-induced hepatitis with increased mast cells in the BALB/c mouse [J].
Njoku, DB ;
Talor, MV ;
Fairweather, D ;
Frisancho-Kiss, S ;
Odumade, OA ;
Rose, NR .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2005, 78 (02) :87-100